EVOK - Evoke Pharma, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
3.17
-0.01 (-0.31%)
As of 12:24PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close3.18
Open3.19
Bid3.17 x 1000
Ask3.23 x 800
Day's Range3.07 - 3.22
52 Week Range1.85 - 4.09
Volume61,764
Avg. Volume85,642
Market Cap53.569M
Beta3.31
PE Ratio (TTM)N/A
EPS (TTM)-0.68
Earnings DateNov 12, 2018 - Nov 16, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.50
Trade prices are not sourced from all markets
  • Evoke Pharma (EVOK) Announces FDA Acceptance of Gimoti NDA
    Zackslast month

    Evoke Pharma (EVOK) Announces FDA Acceptance of Gimoti NDA

    The FDA accepts Evoke Pharma's (EVOK) regulatory application seeking approval of its pipeline candidate, Gimoti, for treating diabetic gastroparesis. Shares up.

  • GlobeNewswirelast month

    Evoke Pharma’s Gimoti™ NDA Accepted for FDA Review

    Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company’s 505(b)(2) New Drug Application (NDA) for Gimoti™, the Company’s nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis, has been accepted for review by the U.S. Food and Drug Administration (FDA). In its Filing Communication/Day-74 letter, FDA stated that the NDA received on June 1, 2018, is sufficiently complete to permit a substantive review and set a target goal date under the Prescription Drug User Fee Act (PDUFA) of April 1, 2019.

  • GlobeNewswirelast month

    Evoke Pharma Reports Second Quarter 2018 Results and Recent Highlights

    Gimoti™ NDA submitted to FDA on June 1 st; awaiting 74- Day FDA filing communication letter. Gender-specific patents granted for Gimoti in the European Union and Mexico. SOLANA BEACH, Calif., Aug. 09, ...

  • At $2.8701, Is Evoke Pharma Inc (NASDAQ:EVOK) A Buy?
    Simply Wall St.3 months ago

    At $2.8701, Is Evoke Pharma Inc (NASDAQ:EVOK) A Buy?

    Evoke Pharma Inc (NASDAQ:EVOK), a pharmaceuticals company based in United States, received a lot of attention from a substantial price increase on the NasdaqCM over the last few months. WithRead More...

  • Evoke Pharma Inc (NASDAQ:EVOK) Is Expected To Breakeven
    Simply Wall St.4 months ago

    Evoke Pharma Inc (NASDAQ:EVOK) Is Expected To Breakeven

    Evoke Pharma Inc’s (NASDAQ:EVOK): Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. On 31 December 2017,Read More...

  • ACCESSWIRE6 months ago

    Evoke Pharma, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 7, 2018 / Evoke Pharma, Inc. (NASDAQ: EVOK ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 7, 2018 at 4:30 PM Eastern Time. To ...

  • ACCESSWIRE9 months ago

    Wired News – Akari’s Phase-II COBALT Trial of Coversin in Patients with PNH Met the Primary Endpoint

    Stock Monitor: Evoke Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 12, 2017 / Active-Investors issued a free report on Akari Therapeutics, PLC (NASDAQ: AKTX ), which is readily accessible ...

  • ACCESSWIRE9 months ago

    Wired News – SteadyMed Reported FDA Agreed Pathway to Trevyent NDA Resubmission

    Stock Monitor: Evoke Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 11, 2017 / Active-Investors issued a free report on SteadyMed Ltd (NASDAQ: STDY ), which is readily accessible upon ...

  • ACCESSWIRE10 months ago

    Evoke Pharma, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 14, 2017 / Evoke Pharma, Inc. (EXCHANGE: EVOK ) will be discussing their earnings results in their Q3 Earnings Call to be held on Tuesday, November 14, 2017 at 4:30 ...

  • A Look At Evoke Pharma Inc (EVOK) And The Healthcare Sector
    Simply Wall St.10 months ago

    A Look At Evoke Pharma Inc (EVOK) And The Healthcare Sector

    Evoke Pharma Inc (NASDAQ:EVOK), a USD$43.09M small-cap, is a healthcare company operating in an industry, which continues to endure a more demanding healthcare agenda, and the global need for innovative,Read More...